T1	SNP 33 50	genetic variation
A1	SNP_Class T1 Common_variant
T2	Entity 123 133;74 89	metabolism steroid hormone
T3	Entity 54 62	61 genes
R1	Member Arg1:T3 Arg2:T2	
T4	Entity 94 133	insulin-like growth factor-I metabolism
R2	Member Arg1:T3 Arg2:T4	
T5	Association 152 156	risk
E1	Association:T5 bc:T6 snp_int:T1
T6	Cancer 138 151	breast cancer
R3	SNP_coupled_gene Arg1:T1 Arg2:T3	
T7	SNP 424 433	variation
T8	Entity 437 491	genes involved in steroid hormone and IGF-I metabolism
R5	Member Arg1:T8 Arg2:T3	
T9	Spec 523 531	evidence
T10	Neg 497 522	yet to provide convincing
R6	Negation_marker Arg1:T9 Arg2:T10	
T11	Association 573 577	risk
E2	Association:T11 snp_int:T7
R7	Speculation_marker Arg1:E2 Arg2:T9	
T12	Entity 663 665	US
T13	Entity 670 678	European
R8	Population_assignment Arg1:T1 Arg2:T12	
R9	Population_assignment Arg1:T1 Arg2:T13	
T14	Level 1016 1029;988 992	significantly None
T15	Association 1030 1040	associated
E3	Association:T15 snp_int:T17 bc:T16
T16	Cancer 1046 1059	breast cancer
T17	SNP 1000 1011	SNPs tested
R10	Level_marker Arg1:E3 Arg2:T14	
A2	Level E3 Low
T18	SNP 701 745	1416 tagging single nucleotide polymorphisms
A3	SNP_Class T18 tSNP
T19	Entity 756 791	37 steroid hormone metabolism genes
T20	Entity 796 818	24 IGF-I pathway genes
R11	SNP_coupled_gene Arg1:T18 Arg2:T19	
R12	SNP_coupled_gene Arg1:T18 Arg2:T20	
T21	Entity 869 885;902 907	mostly Caucasian women
T22	Entity 887 901	postmenopausal
R13	Population_assignment Arg1:T18 Arg2:T21	
R14	Risk_Factor Arg1:T18 Arg2:T22	
T23	Entity 1178 1206	age at diagnosis/recruitment
R16	Risk_Factor Arg1:T17 Arg2:T23	
T24	Entity 1208 1216;1232 1239	advanced disease
T25	Entity 1220 1239	nonadvanced disease
R17	Risk_Factor Arg1:T17 Arg2:T24	
R18	Risk_Factor Arg1:T17 Arg2:T25	
T26	Entity 1241 1256	body mass index
R19	Risk_Factor Arg1:T17 Arg2:T26	
T27	Entity 1274 1287	in situ cases
R20	Risk_Factor Arg1:T17 Arg2:T27	
R21	Population_assignment Arg1:T17 Arg2:T12	
T28	Entity 1306 1316	Caucasians
R22	Population_assignment Arg1:T17 Arg2:T28	
T29	Level 1417 1438	marginally associated
T30	Association 1454 1458	risk
E4	Association:T30 snp_int:T33 bc:T32
T31	Effect_Type 1444 1453	increased
A4	Effect_Type E4 Increase
A5	Level E4 Low
R23	Effect_type_marker Arg1:E4 Arg2:T31	
R24	Level_marker Arg1:E4 Arg2:T29	
T32	Cancer 1328 1354	estrogen receptor-negative
A6	Cancer_Type T32 ER-
T33	SNP 1365 1368	SNP
T34	Entity 1377 1379	3'
T35	Entity 1383 1406	growth hormone receptor
T36	Entity 1408 1411	GHR
R25	Equiv Arg1:T36 Arg2:T35	
R26	SNP_coupled_gene Arg1:T33 Arg2:T35	
R27	SNP_location Arg1:T33 Arg2:T34	
T37	Level 1533 1547	no significant
T38	Association 1548 1568	overall associations
E5	Association:T38 bc:T39 snp_int:T40
R28	Level_marker Arg1:E5 Arg2:T37	
A7	Level E5 Low
T39	Cancer 1577 1590	breast cancer
T40	SNP 1595 1620	common germline variation
A8	SNP_Class T40 Common_variant
T41	Entity 1624 1632	61 genes
T42	Entity 1645 1660;1671 1681	steroid hormone metabolism
T43	Entity 1665 1681	IGF-I metabolism
R29	SNP_coupled_gene Arg1:T40 Arg2:T41	
R30	Member Arg1:T41 Arg2:T42	
R31	Member Arg1:T41 Arg2:T42	
T44	SNP 1760 1770	variations
R32	Equiv Arg1:T44 Arg2:T40	
T45	Organic_inorganic_molecules_affected 1819 1825	levels
E6	Organic_inorganic_molecules_affected:T45 Theme:T46 Agent:T44
T46	Entity 1800 1818	endogenous hormone
T47	SNP 1858 1869	single SNPs
R33	Equiv Arg1:T40 Arg2:T47	
T48	Neg 1875 1878	not
T49	Spec 1879 1885	appear
T50	Association 1906 1911	alter
E7	Association:T50 snp_int:T44 bc:T51
R34	Speculation_marker Arg1:E7 Arg2:T49	
R35	Negation_marker Arg1:E7 Arg2:T48	
T51	Cancer 1912 1925	breast cancer
R15	Equiv Arg1:T17 Arg2:T40	
R37	Member Arg1:T8 Arg2:T19	
R38	Member Arg1:T8 Arg2:T20	
R39	Member Arg1:T17 Arg2:T33	
R40	Member Arg1:T17 Arg2:T18	
R4	Member Arg1:T18 Arg2:T1	
T52	Spec 14 22	analysis
R36	Speculation_marker Arg1:E1 Arg2:T52	
A9	SNP_Class T7 Common_variant
